Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes - Takeaways - MDSpire

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

  • By

  • Sanna Leinonen

  • Rupert Bourne

  • Adam LaMontagne

  • Gordana Sunaric Mégevand

  • May 21, 2026

  • 0 min

Share

  • 1

    Myopia is a significant global health issue, with predictions indicating that by 2050, half of the world population will be myopic.

  • 2

    High myopia increases the risk of primary open-angle glaucoma, with a pooled odds ratio of 1.8–1.9 for developing the condition.

  • 3

    Distinguishing between myopic changes and glaucomatous damage is challenging, complicating diagnosis and monitoring in myopic patients.

  • 4

    A survey of European Glaucoma Society members identified critical research areas in glaucoma diagnostics and treatment for myopic eyes.

  • 5

    The survey revealed that the most pressing questions involve differentiating glaucomatous changes from myopic changes using OCT and visual field tests.

Original Source(s)

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

  • by Sanna Leinonen, Rupert Bourne, Adam LaMontagne, Gordana Sunaric Mégevand

  • May 21, 2026

Related Content

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

The fellow eye effect

Risk Factors of Myopia

Myopia is surging globally, driven by lifestyle factors, with outdoor time offering key protection